Pages that link to "Q53657096"

The following pages link to Prognostic role of E2F1 and members of the CDKN2A network in gastrointestinal stromal tumors. (Q53657096):

Displaying 34 items.

• Identification of tumor suppressors and oncogenes from genomic and epigenetic features in ovarian cancer (Q28741689) (← links)
• P53 expression is significantly correlated with high risk of malignancy and epithelioid differentiation in GISTs. An immunohistochemical study of 104 cases (Q33354638) (← links)
• Prognostic value of KIT/PDGFRA mutations in gastrointestinal stromal tumors: a meta-analysis (Q33712862) (← links)
• Correlation between KIT expression and KIT mutation in melanoma: a study of 173 cases with emphasis on the acral-lentiginous/mucosal type (Q33995919) (← links)
• Immune cells in primary and metastatic gastrointestinal stromal tumors (GIST). (Q34028872) (← links)
• Loss of chromosome 9p21 and decreased p16 expression correlate with malignant gastrointestinal stromal tumor (Q34183218) (← links)
• Array comparative genomic hybridization analysis of chromosomal imbalances and their target genes in gastrointestinal stromal tumors (Q34576648) (← links)
• Genetic aberrations of gastrointestinal stromal tumors (Q34594996) (← links)
• Emerging roles of E2Fs in cancer: an exit from cell cycle control (Q35009182) (← links)
• Prognostic significance of promyelocytic leukemia expression in gastrointestinal stromal tumor; integrated proteomic and transcriptomic analysis (Q35051310) (← links)
• Expression of DOG1, PDGFRA, and p16 in Gastrointestinal Stromal Tumors (Q35119141) (← links)
• An update on molecular genetics of gastrointestinal stromal tumours. (Q35770066) (← links)
• Improved detection of KIT exon 11 duplications in formalin-fixed, paraffin-embedded gastrointestinal stromal tumors (Q35789573) (← links)
• Genomic Grade Index predicts postoperative clinical outcome of GIST. (Q36387916) (← links)
• Duodenal GIST: a single center experience (Q36803986) (← links)
• p16 expression differentiates high-risk gastrointestinal stromal tumor and predicts poor outcome (Q36897784) (← links)
• Proteomic approach toward personalized sarcoma treatment: lessons from prognostic biomarker discovery in gastrointestinal stromal tumor (Q38071053) (← links)
• Transcription addiction: can we garner the Yin and Yang functions of E2F1 for cancer therapy? (Q38237693) (← links)
• Clinical development landscape in GIST: from novel agents that target accessory pathways to revisiting non-targeted therapies (Q38925022) (← links)
• A meta-analysis of prognostic value of KIT mutation status in gastrointestinal stromal tumors (Q39650027) (← links)
• Molecular and functional characterization of a new 3' end KIT juxtamembrane deletion in a duodenal GIST treated with neoadjuvant Imatinib (Q41347601) (← links)
• Cyclin-Dependent Kinase Activity Correlates with the Prognosis of Patients Who Have Gastrointestinal Stromal Tumors (Q41365125) (← links)
• Diagnostic and prognostic markers for gastrointestinal stromal tumors in Norway (Q45023853) (← links)
• Expression of cell cycle regulators and frequency of TP53 mutations in high risk gastrointestinal stromal tumors prior to adjuvant imatinib treatment (Q49924821) (← links)
• Wnt/β-catenin Signaling Contributes to Tumor Malignancy and Is Targetable in Gastrointestinal Stromal Tumor. (Q50435067) (← links)
• Inactivating Mutations of RB1 and TP53 Correlate With Sarcomatous Histomorphology and Metastasis/Recurrence in Gastrointestinal Stromal Tumors (Q51232554) (← links)
• [Multilayer analysis of signal transduction and cell cycle control in GIST. Identifying new interaction partners with differential regulation]. (Q53305917) (← links)
• Heterozygosity Loss at 22q and Lack of INI1 Gene Mutation in Gastrointestinal Stromal Tumor (Q54587404) (← links)
• Epithelioid/mixed phenotype in gastrointestinal stromal tumors with KIT mutation from the stomach is associated with accelerated passage of late phases of the cell cycle and shorter disease-free survival (Q54650490) (← links)
• Combined DNA methylation and gene expression profiling in gastrointestinal stromal tumors reveals hypomethylation ofSPP1as an independent prognostic factor (Q57325993) (← links)
• Site-dependent differential KIT and PDGFRA expression in gastric and intestinal gastrointestinal stromal tumors (Q80731955) (← links)
• [Molecular biological evaluation of prognostic parameters in GIST. Development of an integrative model of tumor progression] (Q84757222) (← links)
• Prognostic value of E2F1 in rectal cancer (Q89064978) (← links)
• Driver gene alterations and activated signaling pathways toward malignant progression of gastrointestinal stromal tumors (Q90278143) (← links)